Carcinogenic |
Midkine |
Endogenous |
Mitogenic, transformation |
Kadomatsu and Muramatsu (2004) |
Pleiotrophin |
Endogenous |
Mitogenic, transformation |
Kadomatsu and Muramatsu (2004) |
Hepatocyte growth factor |
Endogenous |
Cancer development |
Tate et al. (2006) |
K-Ras4B |
Endogenous |
Cancer development |
Birchenall-Roberts et al. (2006) |
P-selectin |
Endogenous |
Signal transduction |
Reyes-Reyes and Akiyama (2008) |
ErbB receptors |
Endogenous |
Malignant transformation |
Di Segni et al. (2008) |
Tipα |
H. pylori
|
Tumor promotion and progression |
Watanabe et al. (2010b) |
Anti-carcinogenic |
HB-19 |
Synthesized |
Anti-HIV infection, anti-carcinogenic activity |
Nisole et al. (2002) |
Lactoferrin |
Cow’s milk |
Anti-carcinogenic activity |
Legrand et al. (2004) |
AS1411/GROs |
Synthesized |
Anti-carcinogenic activity |
Ireson and Kelland (2006) |
Endostatin |
Endogenous |
Anti-angiogenic, anti-carcinogenic activities |
Shi et al. (2007) |
N6L |
Synthesized |
Anti-carcinogenic activity |
Destouches et al. (2011) |
Disease-related |
Lipoproteins |
Endogenous |
Lipid homeostasis |
Semenkovich et al. (1990) |
Laminin |
Endogenous |
Neurite outgrowth |
Kleinman et al. (1991) |
Fructosyllysine |
Endogenous |
Cell attachment |
Krantz et al. (1995) |
Group B coxsackievirus |
CVB |
Viral infection |
de Verdugo et al. (1995) |
Factor J |
Endogenous |
Complement inhibitor |
Larrucea et al. (1998) |
HIV |
HIV |
Viral infection |
Nisole et al. (1999) |
Elongation factor Tu |
Francisella tularensis
|
Bacterial infection |
Barel et al. (2008) |
Intimin-γ |
Escherichia coli O157:H7 |
Bacterial adherence |
Sinclair and O’Brien (2002) |
RSV |
RSV |
Viral infection |
Tayyari et al. (2011) |
Aβ42 |
Endogenous |
Alzheimer’s disease |
Ozawa et al. (2013) |